课题基金 / 基金详情

Inhibiting protein-protein interactions in the early stages of amyloid formation

Inhibiting protein-protein interactions in the early stages of amyloid formation
在淀粉样蛋白形成的早期阶段抑制蛋白质-蛋白质相互作用
批准号:
2270523
负责人:
金额:
$0.0万
依托单位:
依托单位国家:
英国
项目类别:
Studentship
财政年份:
2019
资助国家:
英国
项目状态:
已结题
起止时间:
2019 至 --

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
In this project we focus on aggregation of Islet Associated PolyPeptide (IAPP) (type II diabetes) and A-beta (Alzheimer's). Increasing evidence suggests that the intrinsically disordered monomers of these proteins are in dynamic equilibrium with aggregation-prone oligomers. Despite significant progress in the characterization of IAPP/A-beta aggregation, mechanistic understanding of their folding/aggregation mechanisms remains obscure and new fundamental knowledge is needed to inform the design of therapies.Objectives: Combining native MS with biochemical/biophysical assays we will:1. Explore how small molecule inhibitors affect IAPP/A-beta aggregation: using MS, IMS and kinetic assays (ThT fluorescence) we will screen for new small molecule inhibitors of aggregation using 'hits' recently discovered in SER's lab (Nature Chem (2015) and Nature Chem Biol (2016)). Using MS mapping with ETD (FS: Anal Chem (2016)) combined with other solution-based assays we will elucidate which species are responsible for interactions with different inhibitors and characterize inhibitor binding interfaces. We will then use cell biological assays to determine whether the inhibitors affect cytotoxicity.2. Explore the sequence-dependence of aggregation: using a novel screen for aggregation developed in SER's laboratory (Nature Chem Biol (2016)) we will select IAPP/A-beta sequences with altered aggregation properties. We will then select for mutations that enhance/retard disease progression and thus, elucidate how these mutations perturb folding and aggregation. Novelty/Timeliness:To our knowledge the project will reveal the first atomistic insights into the energy landscapes of folding/aggregation. By focusing on peptides that are the causative agent of amyloid associated with type II diabetes/Alzheimer's the results will also have impact on human health today.Experimental Approach:We will utilize native MS to the full for the project, and combine this with chemical biology, biophysics and cell biology, offering the student training in a wide range of techniques. All methods are up and running, enabling the student to make rapid progress.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
子宫内膜间质与巨噬细胞之间通过Protein S-MerTK-Apelin信号对 话促进子宫腺肌病蜕膜化缺陷的机制研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    吕海宁
  • 依托单位:
有翅与无翅蚜虫差异分泌唾液蛋白Cuticular protein在调控植物细胞壁免疫中的功能
  • 批准号:
    32372636
  • 项目类别:
    面上项目
  • 资助金额:
    50.00万元
  • 批准年份:
    2023
  • 负责人:
    郭慧娟
  • 依托单位:
原发性开角型青光眼中SIPA1L1促进小梁网细胞外基质蛋白累积升高眼压的作用机制
  • 批准号:
    82371054
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    郭涛
  • 依托单位:
胆固醇合成蛋白CYP51介导线粒体通透性转换诱发Th17/Treg细胞稳态失衡在舍格伦综合征中的作用机制研究
  • 批准号:
    82370976
  • 项目类别:
    面上项目
  • 资助金额:
    48.00万元
  • 批准年份:
    2023
  • 负责人:
    郑凌艳
  • 依托单位: